ARS Pharmaceuticals
Maker of the first FDA-approved needle-free nasal spray for severe allergic reactions.
$5.99
After-hours close+0.10 (+1.78%)
At close$5.89(−2.40%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.33 | — | — |
| Aug 2026 | −$0.48 | −$0.63 | −31.9% |
| May 2026 | −$0.53 | −$0.61 | −15.1% |
| Mar 2026 | −$0.42 | −$0.42 | 0.0% |
| Nov 2025 | −$0.45 | −$0.52 | −15.6% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.33 | — | — | $44.8M | — | — |
| Aug 13, 2026 | −$0.48 | −$0.63 | −31.9% | $31.3M | $33.7M | +7.5% |
| May 15, 2026 | −$0.53 | −$0.61 | −15.1% | $22.2M | $22.7M | +2.2% |
| Mar 9, 2026 | −$0.42 | −$0.42 | 0.0% | $25.6M | $28.1M | +9.7% |
| Nov 10, 2025 | −$0.45 | −$0.52 | −15.6% | $25.6M | $32.5M | +27.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 13, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 21, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 29, 2021 | ||||||
| Nov 10, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||